Drew Hoffman
dhoffman@echo.globaland/or marketing@echo.global
405.279.6664
November 1, 2022
OKLAHOMA CITY – Echo-backed global production company Prairie Surf Media recently completed work on Season 1 of “Tulsa King,” a crime drama starring Sylvester Stallone. The Paramount+ drama series premiers Nov. 13. Prairie Surf Studios, headquartered in Oklahoma City, features 1.3 million square feet, five soundstages, and access to the world’s most diverse ecoregions. Check out the must-see “Tulsa King” series trailer
Watch Now
October 21, 2022
Zeno Technologies today unveiled a new cloud-based platform to help energy companies, investors and partners adapt and thrive in the face of new market realities in the Production Era. The energy industry is fundamentally different than it was just a few short years ago, and today’s energy-focused organizations need a set of modern tools to unlock data to inform smarter, faster business decisions. Zeno’s new Energy Operating System provides the clarity to understand and improve business performance, and the insight to decisively assess and pursue new investment opportunities.
Read More
October 9, 2022
Oklahoma City, long guided by waves of corporate leaders, is seeing a new, younger generation lining up behind aging baby boomers and reshaping their community economically, culturally and philanthropically. Chad Richison, 51, Christian Kanady, 43, and Bob Funk Jr., 47, are among a growing number of Gen Xers (born between 1965 and 1980) who are taking Oklahoma City in a new direction where oil and gas is giving way to a new, more diverse economy.
Read More
October 4, 2022
OKLAHOMA CITY – Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in small batch clinical production of biologics and GMP-grade reagents using their open-source platform, Portable CMC™, today announced the first closing of their Series A financing round. The round was co-led by Charles River Laboratories and Echo Investment Capital with participation from ATUM, Floating Point Advisors, Plains Venture Partners (a subsidiary of i2E), and Pine Ridge Ventures.
Read More
September 8, 2022
Deka Biosciences ("Deka"), a biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases, announced today the appointment of Charlotte Moser, MD, PhD, MSc, MBA as Chief Medical Officer (CMO) and Deb Kientop, MBA as Vice President, Clinical Operations.
Read More